NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/14/2025
Back to search
Official data from USPTO
CLINITEST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINITEST
ST13
US500000087704620Class
1, 10
Filing
87704620
Registration
5636199
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
03/15/2025
Trademark type
Word
Nice classes
1, 10
Filing date
12/01/2017
Registration date
12/25/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2025
Last transaction
03/15/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
12/31/2003
First use in commerce
12/31/2003
Drawing code
4
Owner type
03
Owner location
Tarrytown, NY
Examiner
AVENT, TEAGUE
Current location
Historical data usage
Holders and representatives
Holders
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Representatives
Andrew Chien SIEMENS HEALTHCARE DIAGNOSTICS INC.
Technical classification
Nice Classes
Class 1Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Immunoassay diagnostic kits for human chorionic gonadotropin (HCG) consisting primarily of in vitro diagnostic reagents for laboratory purposes; preparation for use as an indicator for determining the presence or absence of HCG in urine for medical laboratory purposes; Diagnostic preparations for clinical or medical laboratory use
Class 10
medical diagnostic test kit comprising of pipettes and test cassettes for diagnosis of pregnancy in humans
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2025
E815
TEAS SECTION 8 & 15 RECEIVED
11/15/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/26/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/26/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/26/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/23/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2018
GNRT
NON-FINAL ACTION E-MAILED
02/06/2018
CNRT
NON-FINAL ACTION WRITTEN
02/06/2018
DOCK
ASSIGNED TO EXAMINER
01/30/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2017
NWAP
NEW APPLICATION ENTERED
12/05/2017
Continuous trademark protection
Get notified about every new filing that threatens CLINITEST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.